Literature DB >> 3287561

Clinical disease spectrum and pathogenic factors associated with Plesiomonas shigelloides infections in humans.

R A Brenden1, M A Miller, J M Janda.   

Abstract

Plesiomonas shigelloides is a gram-negative, facultatively anaerobic rod whose appropriate taxonomic position is presently under investigation. The isolation and identification of this microorganism in contaminated specimens (e.g., feces) by a clinical laboratory depend on the screening of gram-negative colonies for oxidase and indole positivity and the appropriate use of selective and differential agars. Plesiomonads have been associated with extraintestinal diseases (bacteremia, meningitis) on rare occasions; they have been recovered sporadically from patients presenting with acute gastroenteritis. Although case reports and epidemiologic data support a role for P. shigelloides in diarrheal disease, laboratory investigations have failed to identify an enteropathogenic mechanism in these bacteria consistently or to reveal an animal model that faithfully reproduces the disease. Moreover, studies with volunteers have failed to establish an etiologic relation between Plesiomonas and bacterial gastroenteritis. An accurate picture of the role of this bacterium in human disease must await future studies.

Entities:  

Mesh:

Year:  1988        PMID: 3287561     DOI: 10.1093/clinids/10.2.303

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  31 in total

1.  Two cases of continuous ambulatory peritoneal dialysis-associated peritonitis due to Plesiomonas shigelloides.

Authors:  Patrick C Y Woo; Susanna K P Lau; Samson S Y Wong; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  In vitro susceptibilities of Plesiomonas shigelloides to 24 antibiotics and antibiotic-beta-lactamase-inhibitor combinations.

Authors:  R B Clark; P D Lister; L Arneson-Rotert; J M Janda
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

3.  Microbiological laboratory results from Haiti: June-October 1995.

Authors:  J J Drabick; J M Gambel; E Huck; S De Young; L Hardeman
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

4.  More on the enteropathogenic mechanisms of Plesiomonas shigelloides.

Authors:  D Fumarola; G Miragliotta
Journal:  Eur J Epidemiol       Date:  1989-03       Impact factor: 8.082

5.  Mossambicus tilapia (Oreochromis mossambicus) collected from water bodies impacted by urban waste carries extended-spectrum beta-lactamases and integron-bearing gut bacteria.

Authors:  Nachiket P Marathe; Swapnil S Gaikwad; Ankita A Vaishampayan; Mandar H Rasane; Yogesh S Shouche; Wasudev N Gade
Journal:  J Biosci       Date:  2016-09       Impact factor: 1.826

6.  Expression of hemolytic activity by Plesiomonas shigelloides.

Authors:  J M Janda; S L Abbott
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

7.  Characterization of the Plesiomonas shigelloides genes encoding the heme iron utilization system.

Authors:  D P Henderson; E E Wyckoff; C E Rashidi; H Verlei; A L Oldham
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

8.  Plesiomonas shigelloides enters polarized human intestinal Caco-2 cells in an in vitro model system.

Authors:  C Theodoropoulos; T H Wong; M O'Brien; D Stenzel
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 9.  Pseudomembranous colitis.

Authors:  Priya D Farooq; Nathalie H Urrunaga; Derek M Tang; Erik C von Rosenvinge
Journal:  Dis Mon       Date:  2015-03-11       Impact factor: 3.800

10.  Some properties of Plesiomonas shigelloides treated with aminoglycosides.

Authors:  A Hostacká; I Ciznár
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.